Rockville, MD, United States of America

Barry Falgout



 

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovations of Barry Falgout

Introduction

Barry Falgout is a prominent inventor based in Rockville, MD, who has made significant contributions to the field of vaccine development. He holds a total of seven patents, showcasing his dedication to advancing medical science and public health.

Latest Patents

Among his latest innovations is a dengue tetravalent vaccine that contains a common 30 nucleotide deletion in the 3'-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4. This invention aims to enhance the efficacy of the vaccine against dengue fever, a disease that poses a significant health risk in many tropical and subtropical regions.

Career Highlights

Barry Falgout is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on critical research that addresses global health challenges.

Collaborations

Throughout his career, Barry has collaborated with notable colleagues, including Stephen Whitehead and Brian R Murphy. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of virology.

Conclusion

Barry Falgout's contributions to vaccine development, particularly in relation to dengue fever, highlight his role as a key innovator in the medical field. His work continues to impact public health positively and demonstrates the importance of research in combating infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…